Get started
CELADON PHARMACEUTICALS PLC ORD GBP0.01CC

CELADON PHARMACEUTICALS PLC ORD GBP0.01

4.00GBXD
−0.50−11.11%
As of today at 07:35 GMT
GBX
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

CEL fundamentals

Key facts

Market capitalization‪3.10 M‬GBP
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded2018
Employees (FY)—
CEOJames Short
Websitesummerwaycapital.co.uk
About

Celadon Pharmaceuticals Plc. engages in the research, cultivation, manufacturing and supply of cannabinoid-based medicines. Its focuses on improving quality of life for chronic pain sufferers and exploring the potential of cannabinoid-based medicines for other conditions such as autism. The company was founded in 2018 and is headquartered in London, the United Kingdom.

Ownership
‪‪68.85 M‬‬
Closely held shares
‪‪36.80 M‬‬ (53.45%)
Free Float shares
‪‪32.05 M‬‬ (46.55%)
Closely held shares
‪‪36.80 M‬‬ (53.45%)
Free Float shares
‪‪32.05 M‬‬ (46.55%)
Capital structure
No data available
There's currently no data to show about this capital structure.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪3.10 M‬‬
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
—
Price to sales ratio (P/S)
—
Valuation ratios
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪‪1.20 K‬‬
‪‪2.40 K‬‬
‪‪3.60 K‬‬
‪‪4.80 K‬‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−55,500.0%‬
‪−42,500.0%‬
‪−29,500.0%‬
‪−16,500.0%‬
‪−3,500.0%‬
H2 '22
H1 '23
H2 '23
H1 '24
‪‪−4.50 M‬‬
‪‪−3.00 M‬‬
‪‪−1.50 M‬‬
‪0.00‬
‪‪1.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
No data available
There's currently no revenue data to show for the selected period.

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Celadon
Harley Street
By country
Period: 2023
United Kingdom

Dividends

Dividend yield, history and sustainability

No dividends
CEL has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−5.20 M‬‬
‪‪−2.60 M‬‬
‪0.00‬
‪‪2.60 M‬‬
‪‪5.20 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
Assets
Liabilities